The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–223 of 223
Polo-box domains confer target specificity to the Polo-like kinase family
van de Weerdt, B. C. M., Littler, D. R., Klompmaker, R., Huseinovic, A., Fish, A., Anastassis Perrakis, A., & Medema, R. H. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.02.019 · Cited by 60
Jiang, N., Wang, X., Jhanwar‐Uniyal, M., Darżynkiewicz, Z., & Dai, W. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513156200 · Cited by 60
Emerging cancer therapeutic opportunities by inhibiting mitotic kinases
de Castro, I. P., de Cárcer, G., Montoya, G., & Malumbres, M. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.06.013 · Cited by 58
Cizmecioglu, O., Warnke, S., Arnold, M., Duensing, S. M., & Hoffmann, I. (2008) · Cell Cycle · doi:10.4161/cc.7.22.7071 · Cited by 57
Matthess, Y., Kappel, S., Spänkuch, B., Zimmer, B., Kaufmann, M., & Strebhardt, K. (2005) · Oncogene · doi:10.1038/sj.onc.1208472 · Cited by 57
Self-citationAnti-breast cancer activity of LFM-A13, a potent inhibitor of Polo-like kinase (PLK)
Uckun, F. M., Dıbırdık, İ., Qazi, S., Vassilev, A. O., Ma, H., Mao, C., Benyumov, A. O., & Emami, K. H. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.10.050 · Cited by 57
Chase, D., Feng, Y., HANSHEW, B., Winkles, J. A., Longo, D. L., & Ferris, D. K. (1998) · Biochemical Journal · doi:10.1042/bj3330655 · Cited by 54
Spänkuch, B., Steinhauser, I., Wartlick, H., Kurunci‐Csacsko, E., Strebhardt, K., & Langer, K. (2008) · Neoplasia · doi:10.1593/neo.07916 · Cited by 52
Self-citationReynolds, N., & Ohkura, H. (2003) · Journal of Cell Science · doi:10.1242/jcs.00314 · Cited by 51
Koida, N., Ozaki, T., Yamamoto, H., Ono, S., Koda, T., Ando, K., Okoshi, R., Kamijo, T., Omura, K., & Nakagawara, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710608200 · Cited by 51
Ruan, Q., Wang, Q., Xie, S., Fang, Y., Darżynkiewicz, Z., Guan, K., Jhanwar‐Uniyal, M., & Dai, W. H. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.10.022 · Cited by 48
Yuan, J., Krämer, A., Eckerdt, F., Kaufmann, M., & Strebhardt, K. (2002) · PubMed · Cited by 45
Self-citationExpression of PLK1 and survivin in diffuse large B-cell lymphoma
Liu, L., Zhang, M., & Zou, P. (2007) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190701615918 · Cited by 44
Activation of Polo-like Kinase 3 by Hypoxic Stresses
Wang, L., Gao, J., Dai, W. H., & Lu, L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801326200 · Cited by 42
Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1
Ree, A. H., Bratland, Å., Nome, R. V., Stokke, T., & Fodstad, Ø. (2003) · Oncogene · doi:10.1038/sj.onc.1207000 · Cited by 38
Structure of wild-type Plk-1 kinase domain in complex with a selective DARPin
Bandeiras, T. M., Hillig, R. C., Matias, P. M., Eberspaecher, U., Fanghänel, J., Thomaz, M., Miranda, S., Crusius, K., Pütter, V., Amstutz, P., et al. (2008) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444907068217 · Cited by 38
Tumor inhibition by genomically integrated inducible RNAi-cassettes
Kappel, S., Matthess, Y., Zimmer, B., Kaufmann, M., & Strebhardt, K. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl628 · Cited by 32
Self-citationShimizu‐Yoshida, Y., Sugiyama, K., Rogounovitch, T., Ohtsuru, A., Namba, H., Saenko, V., & Yamashita, S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5993 · Cited by 31
Cell cycle dependent expression of Plk1 in synchronized porcine fetal fibroblasts
Anger, M., Kues, W. A., Klı́ma, J., Mielenz, M., Kubelka, M., Motlík, J., Ešner, M., Dvořák, P., Carnwath, J. W., & Niemann, H. (2003) · Molecular Reproduction and Development · doi:10.1002/mrd.10289 · Cited by 30
Evaluation of Polo-like Kinase 1 inhibition on the G2/M checkpoint in Acute Myelocytic Leukaemia
Didier, C., Cavelier, C., Quaranta, M., Demur, C., & Ducommun, B. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.062 · Cited by 26
Liby, K. T., Wu, H., Ouyang, B., et al. (2001) · DNA sequence · doi:10.3109/10425170109041337 · Cited by 25
von Pawel, J., Reck, M., Digel, W., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.8030 · Cited by 22
Uptake of plasmid-loaded nanoparticles in breast cancer cells and effect on Plk1 expression
Steinhauser, I., Langer, K., Strebhardt, K., & Spänkuch, B. (2009) · Journal of drug targeting · doi:10.1080/10611860903118823 · Cited by 21
Self-citation
Cited by
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Muller, P. A. J., & Vousden, K. H. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.021 · Cited by 1,545
Targeting Mitosis in Cancer: Emerging Strategies
Dominguez-Brauer, C., Thu, K. L., Mason, J. M., Blaser, H., Bray, M. R., & Mak, T. W. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.11.006 · Cited by 495
Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma
Chaisaingmongkol, J., Budhu, A., Dang, H., Rabibhadana, S., Pupacdi, B., Kwon, S. M., Forgues, M., Pomyen, Y., Bhudhisawasdi, V., Lertprasertsuke, N., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.009 · Cited by 434
Jansen, F., Yang, X., Hoelscher, M., Cattelan, A., Schmitz, T., Proebsting, S., Wenzel, D., Vosen, S., Franklin, B. S., Fleischmann, B. K., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001720 · Cited by 430
From Plk1 to Plk5: Functional evolution of polo-like kinases
de Cárcer, G., Manning, G., & Malumbres, M. (2011) · Cell Cycle · doi:10.4161/cc.10.14.16494 · Cited by 273
Metadata
- Authors
- Strebhardt, K.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2010-08
- Volume
- 9
- Issue
- 8
- Pages
- 643-660
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2037874673
- Cited by
- 653
- References
- 223
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.